Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 118

Affinity connects to $80m series C round

MassMutual Ventures and Advance Venture Partners returned to back the relationship management tool provider’s latest round, which brought its overall funding to $120m.

Sep 13, 2021

Lycia Pharmaceuticals rakes in $70m

Eli Lilly and Alexandria Real Estate Equities are among the investors in a round that took the protein drug developer’s total funding to over $150m.

Sep 13, 2021

HomeLane spruces up $50m series E

HomeLane has now taken in over $104m of funding since it was founded, including a series E round backed by Pidilite Group.

Sep 13, 2021

Corporates swoop in for Skydweller’s $40m series A

Palantir and Leonardo have helped solar-powered aircraft technology developer Skydweller fill out its oversubscribed series A funding round.

Sep 13, 2021

Prism BioLab appraises series C round

The Ohara Pharmaceutical-backed small-molecule therapy developer has secured $11.8m from new and returning investors.

Sep 13, 2021

Riverfield flows with fresh funding

Toray Engineering has returned to back a $27.3m round for the surgical robot developer, investing alongside Dai-ichi Life and Medipal Innovation.

Sep 13, 2021

Daily Deal Round Up: September 10, 2021

Myeg returned for augmented reality technology developer HiScene's $41.6m series C-plus round while celiac disease drug developer Calypso Biotech hiked a corporate-backed round to over $33m.

Sep 10, 2021

Snyk snaps up $530m

Atlassian Ventures and Salesforce Ventures have returned to back a primary and secondary series F round for the app security platform developer that included Koch Strategic Platforms.

Sep 10, 2021

Varo Bank cashes in with $510m round

The Progressive-backed neobank has secured the fresh funding at a reported $2.5bn valuation, seven months after it closed a $63m round.

Sep 10, 2021

Mammoth Biosciences raises $195m across two rounds

Disease diagnostics technology developer Mammoth Biosciences is valued at over $1bn following funding rounds backed by investors including Amazon.

Sep 10, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here